These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31128267)

  • 1. Editorial: Antidepressants to the Rescue in Severe Mood Dysregulation and Disruptive Mood Dysregulation Disorder?
    Carlson GA; Klein DN
    J Am Acad Child Adolesc Psychiatry; 2020 Mar; 59(3):339-341. PubMed ID: 31128267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.
    Mayes SD; Waxmonsky JD; Calhoun SL; Bixler EO
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):101-6. PubMed ID: 26745442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample.
    Mayes SD; Mathiowetz C; Kokotovich C; Waxmonsky J; Baweja R; Calhoun SL; Bixler EO
    J Abnorm Child Psychol; 2015 Nov; 43(8):1543-1549. PubMed ID: 26004122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Defining the Clinical Boundary of Disruptive Mood Dysregulation Disorder Symptoms in Youth.
    Stoddard J; Wiggins JL; Wakschlag LS
    J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):216-218. PubMed ID: 33359030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive function in children with disruptive mood dysregulation disorder compared to attention-deficit/hyperactivity disorder and oppositional defiant disorder, and in children with different irritability levels.
    Brænden A; Coldevin M; Zeiner P; Stubberud J; Melinder A
    Eur Child Adolesc Psychiatry; 2024 Jan; 33(1):115-125. PubMed ID: 36680626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double-Blind Randomized Placebo-Controlled Trial of Citalopram Adjunctive to Stimulant Medication in Youth With Chronic Severe Irritability.
    Towbin K; Vidal-Ribas P; Brotman MA; Pickles A; Miller KV; Kaiser A; Vitale AD; Engel C; Overman GP; Davis M; Lee B; McNeil C; Wheeler W; Yokum CH; Haring CT; Roule A; Wambach CG; Sharif-Askary B; Pine DS; Leibenluft E; Stringaris A
    J Am Acad Child Adolesc Psychiatry; 2020 Mar; 59(3):350-361. PubMed ID: 31128268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder.
    Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E
    J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruptive Mood Dysregulation Disorder: Symptomatic and Syndromic Thresholds and Diagnostic Operationalization.
    Laporte PP; Matijasevich A; Munhoz TN; Santos IS; Barros AJD; Pine DS; Rohde LA; Leibenluft E; Salum GA
    J Am Acad Child Adolesc Psychiatry; 2021 Feb; 60(2):286-295. PubMed ID: 32004697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled trial of a computer-based Interpretation Bias Training for youth with severe irritability: a study protocol.
    Haller SP; Stoddard J; MacGillivray C; Stiles K; Perhamus G; Penton-Voak IS; Bar-Haim Y; Munafò MR; Brotman MA
    Trials; 2018 Nov; 19(1):626. PubMed ID: 30428909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruptive mood dysregulation disorder at the age of 6 years and clinical and functional outcomes 3 years later.
    Dougherty LR; Smith VC; Bufferd SJ; Kessel EM; Carlson GA; Klein DN
    Psychol Med; 2016 Apr; 46(5):1103-14. PubMed ID: 26786551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youth.
    Roy AK; Lopes V; Klein RG
    Am J Psychiatry; 2014 Sep; 171(9):918-24. PubMed ID: 25178749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruptive Mood Dysregulation Disorder (DMDD): An RDoC perspective.
    Meyers E; DeSerisy M; Roy AK
    J Affect Disord; 2017 Jul; 216():117-122. PubMed ID: 27554606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic Differences in Disruptive Mood Dysregulation Disorder Symptoms in ADHD, Autism, and General Population Samples.
    Mayes SD; Calhoun SL; Waxmonsky JG; Kokotovich C; Baweja R; Lockridge R; Bixler EO
    J Atten Disord; 2019 Jun; 23(8):849-858. PubMed ID: 27549781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on Disruptive Mood Dysregulation Disorder: A review of the literature.
    Bruno A; Celebre L; Torre G; Pandolfo G; Mento C; Cedro C; Zoccali RA; Muscatello MRA
    Psychiatry Res; 2019 Sep; 279():323-330. PubMed ID: 31164249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-dependent irritability in Attention Deficit/Hyperactivity Disorder: correlates and stability of family-restricted versus cross-situational temper outbursts.
    Courbet O; Slama H; Purper-Ouakil D; Massat I; Villemonteix T
    Child Adolesc Ment Health; 2021 May; 26(2):122-133. PubMed ID: 32558093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a Developmental Nosology for Disruptive Mood Dysregulation Disorder in Early Childhood.
    Wiggins JL; Briggs-Gowan MJ; Brotman MA; Leibenluft E; Wakschlag LS
    J Am Acad Child Adolesc Psychiatry; 2021 Mar; 60(3):388-397. PubMed ID: 32599006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.
    Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Clinical Trial of Dialectical Behavior Therapy for Preadolescent Children With Disruptive Mood Dysregulation Disorder: Feasibility and Outcomes.
    Perepletchikova F; Nathanson D; Axelrod SR; Merrill C; Walker A; Grossman M; Rebeta J; Scahill L; Kaufman J; Flye B; Mauer E; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2017 Oct; 56(10):832-840. PubMed ID: 28942805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.